Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26FM9N4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,925
Award facts
- Contract value 100% obligated
- $13,924.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,924.51 on January 12, 2026, for the supply of CIMZIA 2X200 MG/ML syringe kits. This firm fixed-price delivery order, which is expected to be completed by January 13, 2026, represents a single task order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The parent organization, Cencora, Inc. (doing business as AmerisourceBergen), maintains a substantial IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was competitively awarded with no set-aside designation, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania.
CIMZIA (certolizumab pegol) is a TNF-alpha inhibitor used to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and other autoimmune disorders. This delivery order reflects AmerisourceBergen's critical role in the federal pharmaceutical supply chain, particularly in supporting the Defense Health Agency and military treatment facilities worldwide. The contractor's extensive portfolio of federal medical supply contracts demonstrates its capability to fulfill specialized pharmaceutical procurement requirements across multiple therapeutic domains while maintaining compliance with federal acquisition standards.
Quick answers
Who was awarded contract SPE2DR26FM9N4?
SPE2DR26FM9N4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FM9N4 worth?
The government has obligated $13,925 on SPE2DR26FM9N4.
Is contract SPE2DR26FM9N4 an order under another contract?
Yes. SPE2DR26FM9N4 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM9N4 competed?
The extent of competition for SPE2DR26FM9N4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award